Documents
Application Sponsors
| BLA 019818 | LEADIANT BIOSCI INC | |
Marketing Status
Application Products
| 001 | INJECTABLE;INJECTION | 250 UNITS/ML | 0 | ADAGEN | PEGADEMASE BOVINE |
FDA Submissions
| TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1990-03-21 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1991-06-10 | PRIORITY |
| LABELING; Labeling | SUPPL | 3 | AP | 1991-09-27 | |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1992-04-13 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1992-04-22 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1993-03-09 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 1992-12-28 | PRIORITY |
| LABELING; Labeling | SUPPL | 9 | AP | 1992-11-10 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 1993-08-11 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 13 | AP | 1994-06-16 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 14 | AP | 1993-12-06 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 17 | AP | 1998-09-16 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 23 | AP | 2001-08-17 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 24 | AP | 2002-04-15 | PRIORITY |
| LABELING; Labeling | SUPPL | 34 | AP | 2007-10-26 | STANDARD |
| LABELING; Labeling | SUPPL | 42 | AP | 2008-09-25 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 46 | AP | 2013-01-15 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 47 | AP | 2013-10-07 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 48 | AP | 2013-10-15 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 50 | AP | 2014-01-10 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 51 | AP | 2013-12-17 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 52 | AP | 2014-03-04 | PRIORITY |
| LABELING; Labeling | SUPPL | 53 | AP | 2014-06-05 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 55 | AP | 2014-07-17 | PRIORITY |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 56 | AP | 2015-12-21 | PRIORITY |
Submissions Property Types
| ORIG | 1 | Orphan | 5 |
| SUPPL | 2 | Null | 14 |
| SUPPL | 4 | Null | 14 |
| SUPPL | 5 | Null | 14 |
| SUPPL | 7 | Null | 14 |
| SUPPL | 8 | Null | 14 |
| SUPPL | 11 | Null | 14 |
| SUPPL | 13 | Null | 14 |
| SUPPL | 14 | Null | 14 |
| SUPPL | 17 | Null | 14 |
| SUPPL | 23 | Null | 14 |
| SUPPL | 24 | Null | 14 |
| SUPPL | 46 | Null | 14 |
| SUPPL | 47 | Null | 14 |
| SUPPL | 48 | Null | 14 |
| SUPPL | 50 | Null | 14 |
| SUPPL | 51 | Null | 14 |
| SUPPL | 52 | Null | 14 |
| SUPPL | 53 | Null | 7 |
| SUPPL | 55 | Null | 14 |
| SUPPL | 56 | Null | 14 |
CDER Filings
LEADIANT BIOSCI INC
cder:Array
(
[0] => Array
(
[ApplNo] => 19818
[companyName] => LEADIANT BIOSCI INC
[docInserts] => ["",""]
[products] => [{"drugName":"ADAGEN","activeIngredients":"PEGADEMASE BOVINE","strength":"250 UNITS\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ADAGEN","submission":"PEGADEMASE BOVINE","actionType":"250 UNITS\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)